Treatment of essential hypertension
Stott, D.J.; Ball, S.G.
British Journal of Hospital Medicine 36(4): 261
1986
ISSN/ISBN: 0007-1064 PMID: 2876740 Document Number: 267693
While no consensus over the treatment of essential hypertension has been reached, three recent major trials offer guidance to the clinician. The results of these trials and the role of new and old drugs in the treatment of hypertension are discussed.
Document emailed within 1 workday
Related Documents
Sharma, P.L.; Pandhi, P. 1985: Progress in the treatment of essential hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 23 Suppl. 1: S54-S61Salgueiro Rodríguez, M.; Pérez Pombo, S.; Beiras García, E. 1981: Metoprolol in the treatment of essential hypertension Medicina Clinica 76(3): 121-124
Dosh, S.A. 2002: The treatment of adults with essential hypertension Journal of Family Practice 51(1): 74-80
Gerc, V.; Numić, N. 1984: Modern treatment of essential hypertension Medicinski Arhiv 38(5): 233-238
Kakhnovskiĭ, I.M.; Sivkov, S.I.; Gavrilova, E.N.; Belaia, O.L.; Sivkov, A.S.; Markova, Z.S.; Markov, I.E.; Gaĭdamakina, N.E. 1998: Prestarium treatment of essential hypertension Klinicheskaia Meditsina 76(9): 52-54
Minushkina, L.O.; Sidorenko, B.A. 2003: Metoprolol in the treatment of essential hypertension Kardiologiia 43(11): 102-105
Milei, J.; Lemus, J.; Bernardiner, E. 1986: Ketanserin in the treatment of essential hypertension. a double-blind study against metoprolol and a further long-term open treatment Acta Cardiologica 41(6): 427-441
Staessen, J.; Fagard, R.; Fiocchi, R.; Lijnen, P.; M'Buyamba-Kabangu, J.R.; Amery, A. 1986: Chronic treatment with tibalosine in essential hypertension Archives Internationales de Pharmacodynamie et de Therapie 279(1): 162-176
Ghiuru, R.; Rezuş, C.; Ambăruş, V.; Ionescu, S.; Cosovanu, A. 2001: Nebivolol treatment in essential arterial hypertension Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 105(4): 756-759
Garnier, L.F. 1988: Essential arterial hypertension. from notion to treatment Annales de Cardiologie et d'Angeiologie 37(7): 371-380
Paladini, G.; Sgoifo, E. 1980: Dioodobufenine in the treatment of essential arterial hypertension Minerva Cardioangiologica 28(5): 303-308
Dvorák, I.; Dvorák, M.; Blaha, M.; Kubesová, H.; Havlát, F.; Nĕmcová, H. 1984: Experience with endralazine in the treatment of essential hypertension Vnitrni Lekarstvi 30(1): 42-47
Kennedy, S. 2006: Essential hypertension 2: treatment and monitoring update Community Practitioner: the Journal of the Community Practitioners' and Health Visitors' Association 79(2): 64-66
Pérez-Grovas, H.; Fernández, M.; Arriaga, J.; Herrera-Acosta, J. 1986: Enalapril in the treatment of essential arterial hypertension Archivos del Instituto de Cardiologia de Mexico 56(5): 379-390
Bühler, R.; Laragh, J.H. 1973: Essential hypertension: biochemical analysis--selective treatment Schweizerische Rundschau für Medizin Praxis 62(16): 489-491
Kolesár, J.; Petrovicová, J.; Mikulecký, M.; Mikes, Z.; Hirner, H. 1977: Effect of balneologic treatment on patients with essential hypertension Bratislavske Lekarske Listy 68(3): 301-311
Shoshkes, M. 1974: The use of propranolol with various drug combinations in the treatment of essential hypertension Journal of the Medical Society of New Jersey 71(8): 581-583
Takahashi, H.; Fukuyama, M.; Yoneda, S.; Okabayashi, H.; Yoshimura, M. 1989: Comparison of nisoldipine and atenolol in the treatment of essential hypertension Arzneimittel-Forschung 39(3): 379-382
Marchetta, F.; Chiarini, C.; Degli Esposti, E.; Santoro, A.; Sturani, A.; Zuccalà, A.; Zucchelli, P. 1983: Treatment of essential arterial hypertension with nadolol and bendroflumethiazide La Clinica Terapeutica 106(3): 209-212
Koaté, P.; Diouf, S.; Sylla, M.; Sarr, M.; Ba, S.A. 1983: The place of guanfacine in the treatment of essential arterial hypertension Dakar Medical 28(2): 321-336